Financial Snapshot

Revenue
$35.13M
TTM
Gross Margin
65.08%
TTM
Net Earnings
-$175.5K
TTM
Current Assets
Q3 2020
Current Liabilities
Q3 2020
Current Ratio
167.39%
Q3 2020
Total Assets
Q3 2020
Total Liabilities
$5.273M
Q3 2020
Book Value
$11.43M
Q3 2020
Cash
Q3 2020
P/E
-22.00
Sep 09, 2024 EST
Free Cash Flow
-$174.8K
TTM

Revenues

Revenues

Revenue YoY Change

Revenues

Concept 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

No data

Treasury Stock Shares

No data

Stock Issuance & Repurchase

Ownership Data

Concept 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Dividends

No data

Stock Price

Market Cap: $3.86 Million

About RELIV INTERNATIONAL INC

Reliv' International, Inc. engages in the development, manufacture, and marketing of a proprietary line of nutritional supplements. The company is headquartered in Chesterfield Missouri, Missouri. The firm sells its products through an international network marketing system using independent distributors. The firm operates through a network marketing segment consisting of six operating units that sell nutritional and dietary products to a sales force of independent distributors that sell the products directly to customers. Its products include Reliv Now with Soy; FibRestore; Innergize! Go; LunaRich; ReversAge; Reliv Now for Kids; Arthaffect; ProVantage; SoySentials; CardioSentials; Reliv Defense; RLV Hemp Full Spectrum 750, and others. Its geographic region includes the United States, Australia/New Zealand, Canada, Mexico, Europe and Asia. Its subsidiaries include Reliv, Inc., Reliv World Corporation, Reliv Australia Pty, Limited, Reliv Now de Mexico, S. de R.L. de C.V. and others.

Industry: Pharmaceutical Preparations Peers: CV Sciences, Inc. Merion, Inc. ESTEE LAUDER COMPANIES INC Genufood Energy Enzymes Corp. Guardion Health Sciences, Inc. KONA GOLD BEVERAGE, INC. LiveWire Ergogenics, Inc. MusclePharm Corp